Relationships between Clinicopathological Features and Cerebrospinal Fluid Biomarkers in Japanese Patients with Genetic Prion Diseases

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Higuma, Maya ^a   Sanjo, Nobuo ^a   Satoh, Katsuya ^b   Shiga, Yusei ^c   Sakai, Kenji ^d   Nozaki, Ichiro ^d   Hamaguchi, Tsuyoshi ^d   Nakamura, Yosikazu ^e   Kitamoto, Tetsuyuki ^f   Shirabe, Susumu ^g   Murayama, Shigeo ^h   Yamada, Masahito ^d   Tateishi, Jun ⁱ   Mizusawa, Hidehiro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c Aoba Neurosurgical Clinic   (Japan)

^d KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^h TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

ⁱ Harukaze Healthcare Service Institution   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; PROTEIN 14 3 3; TAU PROTEIN;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN HOMOGENATE; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; DISEASE DURATION; FEMALE; GENE MUTATION; GENETIC PRION DISEASE; GENOTYPE; GERSTMANN STRAUSSLER SCHEINKER DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; ONSET AGE; PRION DISEASE; PRION PROTEIN GENE; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN METABOLISM; PROTEIN SECRETION; SYNAPSE; WESTERN BLOTTING;

14-3-3 PROTEINS; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; FEMALE; GENOTYPE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PRION DISEASES; PRIONS;

EID: 84875543960     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060003     Document Type: Article

References (33)

1. van der Kamp MW, Daggett V, (2009) The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel 22 (8): 461-468 doi:10.1093/protein/gzp039.
2. Kovács GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, et al. (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118 (2): 166-174 doi:10.1007/s00439-005-0020-1.
3. Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, et al. (2010) Prospective 10-year surveillance of human prion diseases in Japan. Brain 133 (10): 3043-3057 doi:10.1093/brain/awq216.
4. Ladogana A, Sanchez-Juan P, Mitrova E, Green A, Cuadrado-Corrales N, et al. (2009) Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol 256 (10): 1620-1628 doi:10.1007/s00415-009-5163-x.
5. Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, et al. (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17 (2): 175-178 doi:10.1038/nm.2294.
6. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, et al. (2007) Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nature Methods 4 (8): 645-650 doi:10.1038/nmeth1066.
7. Shiga Y, Satoh K, Kitamoto T, Kanno S, Nakashima I, et al. (2007) Two different clinical phenotypes of Creutzfeldt-Jakob disease with a M232R substitution. J Neurol 254 (11): 1509-1517 doi:10.1007/s00415-007-0540-9.
8. Majtenyi C, Brown P, Cervenakova L, Goldfarb LG, Tateishi J, (2000) A three-sister sibship of Gerstmann-Straussler-Scheinker disease with a CJD phenotype. Neurology 54 (11): 2133-2137.
9. Webb TE, Poulter M, Beck J, Uphill J, Adamson G, et al. (2008) Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 131 (10): 2632-2646 doi:10.1093/brain/awn202.
10. Kitamoto T, Ohta M, Doh-ura K, Hitoshi S, Terao Y, et al. (1993) Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun 191 (2): 709-714.
11. Satoh K, Tobiume M, Matsui Y, Mutsukura K, Nishida N, et al. (2010) Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Lab Invest 90 (11): 1637-1644 doi:10.1038/labinvest.2009.68.
12. Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, et al. (2006) 14-3-3 Protein, Total Tau and Phosphorylated Tau in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease and Neurodegenerative Disease in Japan. Cellular and Molecular Neurobiology 26 (1): 45-52 doi:10.1007/s10571-006-9370-z.
13. Kitamoto T, Shin R-W, Doh-ura K, Tomokane N, Miyazono M, et al. (1992) Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 140 (6): 1285-1294.
14. Shimizu S, Hoshi K, Muramoto T, Homma M, Ironside JW, et al. (1999) Creutzfeldt-Jakob Disease With Florid-Type Plaques After Cadaveric Dura Mater Grafting. Arch Neurol 56: 357-362.
15. Tateishi J, Kitamoto T, (1995) Inherited prion diseases and transission to Rodents. Brain Pathol 5 (1): 53-59.
16. McGuire LI, Peden AH, Orrú CD, Wilham JM, Appleford NE, et al. (2012) RT-QuIC analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Annals of Neurology in press.
17. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, et al. (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39 (6): 767-778 doi:10.1002/ana.410390613.
18. Chasseigneaux S, Haïk S, Laffont-Proust I, De Marco O, Lenne M, et al. (2006) V180I mutation of the prion protein gene associated with atypical PrPSc glycosylation. Neuroscience Letters 408 (3): 165-169 doi:10.1016/j.neulet.2006.08.008.
19. Yamada M, Itoh Y, Inaba A, Wada Y, Takashima M, et al. (1999) An inherited prion disease with a PrP P105L mutation: clinicopathologic and PrP heterogeneity. Neurology 53 (1): 181-188.
20. Shimizu H, Yamada M, Matsubara N, Takano H, Umeda Y, et al. (2009) Creutzfeldt-Jakob disease with an M232R substitution: report of a patient showing slowly progressive disease with abundant plaque-like PrP deposits in the cerebellum. Neuropathol 29 (6): 735-743 doi:10.1111/j.1440-1789.2009.01019.x.
21. Hama T, Iwasaki Y, Niwa H, Yoshida M, Hashizume Y, et al. (2009) An autopsied case of panencephalopathic-type Creutzfeldt-Jakob disease with mutation in the prion protein gene at codon 232 and type 1 prion protein. Neuropathol 29 (6): 727-734 doi:10.1111/j.1440-1789.2009.01016.x.
22. Iwasaki Y, Mori K, Ito M, Nagaoka M, Ieda T, et al. (2011) An autopsied case of V180I Creutzfeldt-Jakob disease presenting with panencephalopathic-type pathology and a characteristic prion protein type. Neuropathol 31 (5): 540-548 doi:10.1111/j.1440-1789.2010.01192.x.
23. Parchi P, Chen SG, Brown P, Zou W, Capellari S, et al. (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc Natl Acad Sci U S A 95 (14): 8322-8327.
24. Popova S, Tarvainen I, Capellari S, Parchi P, Hannikainen P, et al. (2012) Divergent clinical and neuropathological phenotype in a Gerstmann-Sträussler-Sheinker P102L family. Acta Neurol Scand in press. doi:10.1111/j.1600-0404.2011.01628.x.
25. Iwasaki Y, Kizawa M, Hori N, Kitamoto T, Sobue G, (2009) A case of Gerstmann-Sträussler-Scheinker syndrome with the P105L prion protein gene mutation presenting with ataxia and extrapyramidal signs without spastic paraparesis. Clin Neurol Neurosurg 111 (7): 606-609 doi:10.1016/j.clineuro.2009.03.008.
26. Shiraishi A, Mizusawa H, Yamada M, (2002) Early and persistent sensory-psychiatric symptoms in an inherited prion disease with a PrP P105L mutation. J Neurol 249 (12): 1740-1741 doi:10.1007/s00415-002-0907-x.
27. Jin K, Shiga Y, Shibuya S, Chida K, Sato Y, et al. (2004) Clinical features of Creutzfeldt-Jakob disease with V180I mutation. Neurology 62 (3): 502-505.
28. Yang T-I, Jung D-S, Ahn B-Y, Jeong B-H, Cho H-J, et al. (2010) Familial Creutzfeldt-Jakob Disease with V180I Mutation. J Korean Med Sci 25 (7): 1097 doi:10.3346/jkms.2010.25.7.1097.
29. Choi B-Y, Kim SY, Seo S-Y, An SSA, Kim S, et al. (2009) Mutations at codons 178, 200-129, and 232 contributed to the inherited prion diseases in Korean patients. BMC Infect Dis 9 (1): 132 doi:10.1186/1471-2334-9-132.
30. Zheng L, Longfei J, Jing Y, Xinqing Z, Haiqing S, et al. (2008) PRNP mutations in a series of apparently sporadic neurodegenerative dementias in China. Am J Med Genet B Neuropsychiatr Genet 147B (6): 938-944 doi:10.1002/ajmg.b.30761.
31. Beck J, Collinge J, Mead S (2012) Prion protein gene M232R variation is probably an uncommon polymorphism rather than a pathogenic mutation. Brain: a journal of neurology 135 (Pt 2): e209; author reply e210. doi:10.1093/brain/awr294.
32. Meiner Z, Kahana E, Baitcher F, Korczyn AD, Chapman J, et al. (2011) Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J Neurol 258 (2): 255-262 doi:10.1007/s00415-010-5738-6.
33. Prusiner SB, (1991) Molecular biology of prion diseases. Science 252 (5012): 1515-1522.